scholarly journals Is There Really a Sex Recession? Period and Cohort Effects on Sexual Inactivity Among American Men, 2006–2019

2021 ◽  
Vol 15 (6) ◽  
pp. 155798832110577
Author(s):  
Robert Bozick

There has been a growing concern among researchers and media commentators that men in the United States may be increasingly less sexually active, creating a form of a “sex recession.” Using 14 years of survey data from men in the National Survey of Family Growth (2006–2019), this study assesses whether such concerns are warranted. Cross-classified mixed-effects models are estimated to ascertain whether there is evidence of a population-wide sex recession among men due to secular conditions specific to different time periods, or if birth cohorts that comprise the male population at any given point in time are exhibiting distinct patterns of sexual behavior. The analysis finds no evidence of a population-wide sex recession among men. Rates of sexual inactivity among men have been constant across the time series, but those born between 2000 and 2004 had significantly higher rates of sexual inactivity than previous birth cohorts did at the same age. Additionally, men who are unemployed and/or living at home with their parents are more likely to refrain from sexual intercourse than their peers who are employed and/or living independently of their parents.

2020 ◽  
Vol 6 ◽  
pp. 237802312090847
Author(s):  
Lawrence L. Wu ◽  
Steven P. Martin ◽  
Paula England ◽  
Nicholas D. E. Mark

In this data visualization, the authors document trends in abstaining from sex while never married for U.S. women born 1938–1939 to 1982–1983. Using data from the six most recent National Surveys of Family Growth, the authors’ estimates suggest that for women born in the late 1930s and early 1940s, 48 percent to 58 percent reported abstaining from sex while never married. Abstinence then declined rapidly among women born in the late 1940s through the early 1960s, leveling off at between 9 percent and 12 percent for more recent birth cohorts. Thus, for U.S. women born between the mid-1960s and the early 1980s, roughly one in nine abstained from sex while never married.


2021 ◽  
Vol 49 (4) ◽  
pp. 389-418
Author(s):  
Joseph A. Stanley ◽  
Margaret E. L. Renwick ◽  
Katherine Ireland Kuiper ◽  
Rachel M. Olsen

Southern American English is spoken in a large geographic region in the United States. Its characteristics include back-vowel fronting (e.g., in goose, foot, and goat), which has been ongoing since the mid-nineteenth century; meanwhile, the low back vowels (in lot and thought) have recently merged in some areas. We investigate these five vowels in the Digital Archive of Southern Speech, a legacy corpus of linguistic interviews with sixty-four speakers born 1886-1956. We extracted 89,367 vowel tokens and used generalized additive mixed-effects models to test for socially-driven changes to both their relative phonetic placements and the shapes of their formant trajectories. Our results reinforce previous descriptions of Southern vowels while contributing additional phonetic detail about their trajectories. Goose-fronting is a change in progress, with greatest fronting after coronal consonants. Goat is quite dynamic; it lowers and fronts in apparent time. Generally, women have more fronted realizations than men. Foot is largely monophthongal, and stable across time. Lot and thought are distinct and unmerged, occupying different regions of the vowel space. While their relative positions change across generations, all five vowels show a remarkable consistency in formant trajectory shapes across time. This study’s results reveal social and phonetic details about the back vowels of Southerners born in the late nineteenth and early twentieth centuries: goose-fronting was well underway, goat-fronting was beginning, but foot remained backed, and the low back vowels were unmerged.


Sexual Health ◽  
2013 ◽  
Vol 10 (4) ◽  
pp. 363 ◽  
Author(s):  
Guoyu Tao ◽  
Karen W. Hoover

Background Men who have sex with men (MSM) experience disparities in access to healthcare and have specific healthcare needs. Methods: We analysed data from the 2006–10 National Survey of Family Growth (NSFG) to examine differences in access to healthcare and HIV and sexually transmissible infection (STI) related health services by MSM and non-MSM among men in the United States aged 15–44 years who have ever had sex. MSM and sexually active MSM were identified in the NSFG as men who had ever had oral or anal sex with another man, or who had sex in the past 12 months with another man, respectively. Access was measured by the type of health insurance, having a usual place for receiving healthcare and type of usual place. Results: Of men aged 15–44 years who have ever had sex, there were no significant differences between MSM and non-MSM in the three access measures. MSM were more likely than non-MSM to receive HIV counselling (22.5% v. 8.3%) and STI testing (26.2% v. 15.6%) in the past 12 months, or to ever have had HIV testing (67.8% v. 44.6%). STI testing in the past 12 months was reported by 38.7% of sexually active MSM. Conclusion: Our findings show no significant differences in access to healthcare between MSM and non-MSM. MSM were more likely to receive HIV- and STI-related preventive services than non-MSM. However, the low STI testing rate among MSM highlights the need for interventions to increase STI testing, and HIV and STI counselling for MSM.


2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Naoto Katakami ◽  
◽  
Tomoya Mita ◽  
Hidenori Yoshii ◽  
Toshihiko Shiraiwa ◽  
...  

Abstract Background Tofogliflozin, an SGLT2 inhibitor, is associated with favorable metabolic effects, including improved glycemic control and serum lipid profile and decreased body weight, visceral adipose tissue, and blood pressure (BP). This study evaluated the effects of tofogliflozin on the brachial-ankle pulse wave velocity (baPWV) in patients with type 2 diabetes (T2DM) without a history of apparent cardiovascular disease. Methods The using tofogliflozin for possible better intervention against atherosclerosis for type 2 diabetes patients (UTOPIA) trial is a prospective, randomized, open-label, multicenter, parallel-group, comparative study. As one of the prespecified secondary outcomes, changes in baPWV over 104 weeks were evaluated in 154 individuals (80 in the tofogliflozin group and 74 in the conventional treatment group) who completed baPWV measurement at baseline. Results In a mixed-effects model, the progression in the right, left, and mean baPWV over 104 weeks was significantly attenuated with tofogliflozin compared to that with conventional treatment (– 109.3 [– 184.3, – 34.3] (mean change [95% CI] cm/s, p = 0.005; – 98.3 [– 172.6, – 24.1] cm/s, p = 0.010; – 104.7 [– 177.0, – 32.4] cm/s, p = 0.005, respectively). Similar findings were obtained even after adjusting the mixed-effects models for traditional cardiovascular risk factors, including body mass index (BMI), glycated hemoglobin (HbA1c), total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, systolic blood pressure (SBP), hypertension, smoking, and/or administration of drugs, including hypoglycemic agents, antihypertensive agents, statins, and anti-platelets, at baseline. The findings of the analysis of covariance (ANCOVA) models, which included the treatment group, baseline baPWV, and traditional cardiovascular risk factors, resembled those generated by the mixed-effects models. Conclusions Tofogliflozin significantly inhibited the increased baPWV in patients with T2DM without a history of apparent cardiovascular disease, suggesting that tofogliflozin suppressed the progression of arterial stiffness. Trial Registration UMIN000017607. Registered 18 May 2015. (https://www.umin.ac.jp/icdr/index.html)


2021 ◽  
pp. 001316442199489
Author(s):  
Luyao Peng ◽  
Sandip Sinharay

Wollack et al. (2015) suggested the erasure detection index (EDI) for detecting fraudulent erasures for individual examinees. Wollack and Eckerly (2017) and Sinharay (2018) extended the index of Wollack et al. (2015) to suggest three EDIs for detecting fraudulent erasures at the aggregate or group level. This article follows up on the research of Wollack and Eckerly (2017) and Sinharay (2018) and suggests a new aggregate-level EDI by incorporating the empirical best linear unbiased predictor from the literature of linear mixed-effects models (e.g., McCulloch et al., 2008). A simulation study shows that the new EDI has larger power than the indices of Wollack and Eckerly (2017) and Sinharay (2018). In addition, the new index has satisfactory Type I error rates. A real data example is also included.


2021 ◽  
Author(s):  
Sonia Bhala ◽  
Douglas R Stewart ◽  
Victoria Kennerley ◽  
Valentina I Petkov ◽  
Philip S Rosenberg ◽  
...  

Abstract Background Benign meningiomas are the most frequently reported central nervous system tumors in the United States (US), with increasing incidence in past decades. However, the future trajectory of this neoplasm remains unclear. Methods We analyzed benign meningioma incidence of cases identified by any means (eg, radiographically with or without microscopic confirmation) in US Surveillance Epidemiology and End Results (SEER) cancer registries among 35–84-year-olds during 2004–2017 by sex and race/ethnicity using age-period-cohort (APC) models. We employed APC forecasting models to glean insights regarding the etiology, distribution, and anticipated future (2018–2027) public health impact of this neoplasm. Results In all groups, meningioma incidence overall increased through 2010, then stabilized. Temporal declines were statistically significant overall and in most groups. JoinPoint analysis of cohort rate-ratios identified substantial acceleration in White men born after 1963 (from 1.1% to 3.2% per birth year); cohort rate-ratios were stable or increasing in all groups and all birth cohorts. We forecast that meningioma incidence through 2027 will remain stable or decrease among 55–84-year-olds but remain similar to current levels among 35–54-year-olds. Total meningioma burden in 2027 is expected to be approximately 30,470 cases, similar to the expected case count of 27,830 in 2018. Conclusions Between 2004–2017, overall incidence of benign meningioma increased and then stabilized or declined. For 2018–2027, our forecast is incidence will remain generally stable in younger age groups but decrease in older age groups. Nonetheless, the total future burden will remain similar to current levels because the population is aging.


2021 ◽  
pp. jim-2020-001525
Author(s):  
Johanna S van Zyl ◽  
Amit Alam ◽  
Joost Felius ◽  
Ronnie M Youssef ◽  
Dipesh Bhakta ◽  
...  

The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic leading to coronavirus disease 2019 (COVID-19) is straining hospitals. Judicious resource allocation is paramount but difficult due to the unpredictable disease course. Once hospitalized, discerning which patients may progress to critical disease would be valuable for resource planning. Medical records were reviewed for consecutive hospitalized patients with COVID-19 in a large healthcare system in Texas. The main outcome was progression to critical disease within 10 days from admission. Albumin trends from admission to 7 days were analyzed using mixed-effects models, and progression to critical disease was modeled by multivariable logistic regression of laboratory results. Risk models were evaluated in an independent group. Of 153 non-critical patients, 28 (18%) progressed to critical disease. The rate of decrease in mean baseline-corrected (Δ) albumin was −0.08 g/dL/day (95% CI −0.11 to −0.04; p<0.001) or four times faster, in those who progressed compared with those who did not progress. A model of Δ albumin combined with lymphocyte percentage predicting progression to critical disease was validated in 60 separate patients (sensitivity, 0.70; specificity, 0.74). ALLY (delta albumin and lymphocyte percentage) is a simple tool to identify patients with COVID-19 at higher risk of disease progression when: (1) a 0.9 g/dL or greater albumin drop from baseline within 5 days of admission or (2) baseline lymphocyte of ≤10% is observed. The ALLY tool identified >70% of hospitalized cases that progressed to critical COVID-19 disease. We recommend prospectively tracking albumin. This is a globally applicable tool for all healthcare systems.


Sign in / Sign up

Export Citation Format

Share Document